About

Alba Fiorentino is a radiation oncologist whose research centers on advancing precision radiotherapy techniques, particularly for prostate and head-and-neck cancers, while also exploring the frontiers of robotic surgery. Her major contributions include pioneering the use of moderate hypofractionated volumetric modulated arc therapy with daily image guidance (VMAT-IGRT) for postprostatectomy patients, demonstrating its feasibility and acceptable acute toxicity in a 2017 study that has garnered 45 citations. She has also critically evaluated patient positioning technologies, such as comparing the ExacTrac x-ray system to cone-beam CT for head-and-neck cancer patients, a 2013 work with 13 citations that informs clinical workflow decisions. Beyond radiation oncology, Fiorentino has contributed to surgical innovation, co-authoring a 2023 report on the first 100 robotic liver resections at her institution (9 citations), highlighting the potential of robotic approaches to overcome laparoscopic limitations. Her work spans from optimizing daily treatment accuracy to expanding minimally invasive surgical options, reflecting a commitment to improving patient outcomes through technological integration. With a career marked by these impactful studies, Fiorentino stands as a key figure in the evolution of image-guided radiotherapy and robotic-assisted procedures.

Research Focus

Key Achievements

3
H-Index
3
Papers
67
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity
45 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Ospedale Sacro Cuore Don Calabria, Centro di Riferimento Oncologico della Basilicata, Ospedale Generale Regionale Francesco Miulli

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago